Replies to post #16360 on Algernon Pharmaceuticals Inc (AGNPF)

[GVX808]

Me likey! :)

[Money $hot]

The following is my reply to your concerns about my last two posts. The first topic being Christopher Moreau calling all shareholders stupid.

If you take what you stated regarding owning approx 65% of DMT as AGN/PF shareholder,,,the question remains how much of Moreau’s prancing peacock PR campaign is Algernon Neuroscience footing the bill? You think it’s OK to own 65% of something and pay 100% of the cost?

YES or NO?

The second topic being Christopher Moreau’s claim that the demonstrably failed COVID-19 Phase 2b “multinational” clinical trial had a 65% Chance Of Success...the question remains will Moreau begin spouting and shouting from pennyland rooftops the DMT program will have a 65% Chance Of Success at Phase 2? That’s assuming they will get beyond Phase 1 of the clinical trial process.

YES OR NO?

The same question can be asked of ANY of the drugs in the pipeline. When does the 55% and/or 65% Chance Of Success become the beating drunk of corporate officers in the know?

If there is any dispute regarding the above 65% number in the first and second instance, please try to address it specifically.

Meanwhile, I assume shell3 would have no dispute about Moreau’s BETTER THAN BACCARAT ODDS for Algernon Pharmaceuticals ``Repurposed Drugs' ' and Non Repurposed Drugs in its pipeline.

According to Algernon leadership...You Get A Car and You Get A Car...!!!



Here’s a post from shell3 (a longtime Moderator here) after observing one of the Biopub Webcasts during the height of the COVID-19 Pandemic:.

shell3 - Friday, February 28, 2020 12:41:10 PM

CEO says 65% success rate factoring in the Drugs have been used and are safe for Humans already

50% success rate for Phase 2 normally but because Human Safe that up success rate to 65%

investorshub.advfn.com/boards/read_msg.aspx?message_id=154076718

Keep in mind, COVID-19 Clinical Trial Probability of Success statement(s) by the CEO and CFO on Biopub were BEFORE they had even filed paperwork with the FDA to begin the clinical trial process.

I Report.

You Decide.

Any Questions?



M$